Literature DB >> 8804489

Neointimized Gore-Tex graft for ureteral prosthesis in the dog.

J J Peters1, W B Shingleton, D Morgan, B Allen, J E Fowler.   

Abstract

OBJECTIVES: To determine the feasibility of replacing a ureteral segment with a neointimized Gore-Tex graft.
METHODS: Seven adult mongrel dogs underwent a two-stage operative procedure. The first procedure involved arterializing the graft to stimulate spread of a luminal neoendothelium by transmural capillary growth. Eight weeks after the initial procedure, a segment of the ipsilateral ureter was replaced with a segment of the neointimized graft.
RESULTS: Histologic evaluation of a portion of the graft removed during the second procedure demonstrated transmural neocapillary ingrowth in all grafts; however, there was no neoendothelial growth on the luminal surface. In 5 dogs the graft was occluded with blood clot and was not suitable for a ureteral prosthesis. In 2 dogs the graft was patent and was successfully incorporated into the urinary system. After 1 year of observation, both of these dogs maintained a patent ureter and had no evidence of hydronephrosis on intravenous urogram.
CONCLUSIONS: These data demonstrate that a Gore-Tex graft can be used as a ureteral prosthesis in the dog. The importance of preliminary arterialization, however, remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8804489     DOI: 10.1016/s0090-4295(96)00163-x

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  2 in total

1.  Intestinal seromuscular tunneling: a novel method for ureteral replacement--an experimental design.

Authors:  Hossein Hodjati; Jalal Khalili Paidar; Perikala Vijayananda Kumar; Hamed Ghoddusi Johari
Journal:  Int Urol Nephrol       Date:  2015-06-10       Impact factor: 2.370

2.  The use of polytetrafluoroethylene (Gore-Tex) grafts in reconstruction of the urinary bladder.

Authors:  F M Senel; R Y Akman; A Y Arikan; M Gürdal; C Can
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.